Skeletal muscle microRNAs as key players in the pathogenesis of amyotrophic lateral sclerosis

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)


Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder, for which, to date, no effective treatment to ameliorate the clinical manifestations is available. The long-standing view of ALS as affecting only motor neurons has been challenged by the finding that the skeletal muscle plays an active role in the disease pathogenesis and can be a valuable target for therapeutic strategies. In recent years, non-coding RNAs, including microRNAs, have emerged as important molecules that play key roles in several cellular mechanisms involved in the pathogenic mechanisms underlying various human conditions. In this review, we summarize how the expression of some microRNAs is dysregulated in the skeletal muscle of ALS mouse models and patients. Shedding light on the mechanisms underlying microRNAs dysregulation in the skeletal muscle could clarify some of the processes involved in the pathogenesis of ALS and especially identify new promising therapeutic targets in patients.
Original languageEnglish
Pages (from-to)1534-N/A
JournalInternational Journal of Molecular Sciences
Publication statusPublished - 2018


  • Amyotrophic lateral sclerosis
  • Gene expression signature
  • MicroRNA
  • Molecular biomarkers
  • Molecularly targeted therapies
  • Skeletal muscle


Dive into the research topics of 'Skeletal muscle microRNAs as key players in the pathogenesis of amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

Cite this